Machine learning-based preoperative prediction of perioperative venous thromboembolism in Chinese lung cancer patients: a retrospective cohort study

  • 0Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.

|

|

Summary

This summary is machine-generated.

Machine learning accurately predicts venous thromboembolism (VTE) risk in lung cancer surgery patients. An extreme gradient boosting model identifies high-risk individuals for personalized prevention strategies.

Area Of Science

  • Oncology
  • Medical Informatics
  • Cardiovascular Medicine

Background

  • Perioperative venous thromboembolism (VTE) is a significant risk for lung cancer patients undergoing surgery.
  • Conventional prediction models struggle with complex clinical data, necessitating advanced approaches.
  • Machine learning (ML) presents a promising avenue for improving VTE risk prediction accuracy.

Purpose Of The Study

  • To develop and validate a machine learning (ML)-based model for preoperative risk assessment of VTE in lung cancer patients.
  • To identify key predictors of VTE in this patient cohort.
  • To create a clinical tool for early VTE risk stratification.

Main Methods

  • Retrospective analysis of 1,013 lung cancer patients undergoing surgery.
  • Identification of six key predictors (age, MCV, MCH, fibrinogen, D-dimer, albumin) using univariate and Lasso regression.
  • Training and evaluation of eight ML models, including XGBoost, Random Forest, and Logistic Regression, using AUC, AUPRC, and calibration curves.

Main Results

  • Venous thromboembolism (VTE) occurred in 17.3% of patients.
  • The extreme gradient boosting (XGB) model exhibited the highest predictive performance (AUC: 0.99 training, 0.66 validation).
  • Age and mean corpuscular volume were identified as the most influential predictors; an online prediction tool was developed.

Conclusions

  • The ML-based XGB model offers a reliable method for preoperative VTE risk assessment in lung cancer surgery.
  • This model facilitates early risk stratification and the implementation of personalized thromboprophylaxis.
  • The developed prediction tool can aid clinicians in managing VTE risk.